Trial intelligence / Profile preview

DPK-060 in Acute External Otitis

NCT01447017Phase 2Completed

Start
Nov 2011
Primary completion
Oct 2012
Modality
Peptides, Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in acute otitis externa (AOE) comparing DPK-060 with Placebo (2 arms). Primary endpoint: Adverse Events. Started Nov 2011; status: completed.

02

Drugs

DPK-060
03

Conditions

acute otitis externa (AOE)

Beyond the preview

Go deeper on NCT01447017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01447017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call